- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Palbociclib – March 2017
Palbociclib: Capsule 75 mg, Capsule 100 mg, Capsule 125 mg; Ibrance®
Last updated
14 July 2017